why choose us

Clinical Trials Search

Showing 17,380 of 132,963 result(s)
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Status: Completed

Condition: Autosomal Dominant Hypocalcemia (ADH)

Interventions: Administered as film-coated tablet for oral use

Date: 2022-12-12

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Status: Completed

Condition: Mucopolysaccharidosis IH;S

Interventions: Autologous plasmablasts (B cells) engineered to express ?-L-iduronidase (IDUA) using the Sleeping Beauty (SB) transposon system.

Date: 2022-12-12

Improving Patient Memory for Treatment for Mild Cognitive Impairment

Status: Completed

Condition: Memory Impairment

Interventions: TranS-C is a psychosocial treatment that helps people who have sleep and circadian problems to improve their sleep health.

Date: 2022-12-12

Drospirenone-only Pill as Emergency Contraception

Status: NOT_YET_RECRUITING

Condition: Contraception

Interventions: Single dose based on adaptive dose-finding design

Date: 2022-12-12

Effect of Stellate Ganglion Block on ME;CFS

Status: ACTIVE_NOT_RECRUITING

Condition: Encephalomyelitis, Myalgic

Interventions:

Reciprocal unilateral stellate ganglion blocks, separated by at least 16 hours, will be given once per week for three weeks (for a total of 6 block

Date: 2022-12-12

Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Status: COMPLETED

Condition: Gout

Interventions: Test the efficacy and safety of SAP 001 versus placebo

Date: 2022-12-12

A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)

Status: COMPLETED

Condition: Chronic Heart Failure With Reduced Ejection Fraction

Interventions: The recommended starting dose of vericiguat is 2.5 mg once daily, taken with food.
The dose of vericiguat would be doubled approximately every 2

Date: 2022-12-12

A Study of GV20-0251 in Patients With Solid Tumor Malignancies

Status: Completed

Condition: Solid Tumor, Adult

Interventions: Increasing doses of GV20-0251 given intravenously as monotherapy.

Date: 2022-12-12

Impact of Bright Light Therapy on Prader-Willi Syndrome

Status: Completed

Condition: Prader-Willi Syndrome

Interventions: Sham treatment will be provided from a light box at a distance of at least 70cm but no greater than 90cm.

Date: 2022-12-12

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC

Status: NOT_YET_RECRUITING

Condition: Locally Advanced Vulvar Carcinoma

Interventions: Paclitaxel 175 mg;m2, followed by carboplatin 5 area under the curve (AUC).
This will be administered in a 3-weekly scheme.

Date: 2022-12-12